Skip to main content
High RiskFDAfda-Z-0988-2022CRASH

Gallant DR Implantable Cardioverter Defibrillator REF # CDDRA500Q

Units Affected
1
Recall Date
March 10, 2022
Issuing Agency
Hazard
Crash

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-Z-0988-2022.

Bluetooth malfunction impacting Gallant devices post-implant. The failure causes the device to enter an inductive-only telemetry mode with a loss of Bluetooth communication. The Bluetooth malfunction results in the inability to remotely monitor these devices and resulted in reduced battery longevity.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-Z-0988-2022.

Recall ongoing. Follow firm instructions.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact St. Jude Medical, Cardiac Rhythm Management Division or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-Z-0988-2022.

St. Jude Medical, Cardiac Rhythm Management Division

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

St. Jude Medical, Cardiac Rhythm Management Division Recall FAQ

St. Jude Medical, Cardiac Rhythm Management Division is the subject of a medical implants safety report: Gallant DR Implantable Cardioverter Defibrillator REF # CDDRA500Q. The notice was published on March 10, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 1 units are potentially affected.